HealthcarePress Releases

Companion Animal Medicine Market Size Predicted to Hit around US$ 40.8 Bn by 2030

The companion animal medicine market size is predicted to hit around US$ 40.8 billion by 2030 and is expected to grow at a compound annual growth rate (CAGR) of 10.6% from 2021 to 2030.

Recently Published Report on “companion animal medicine market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030”.

Companion animal veterinarians treat pets and generally work in private clinics and hospitals. They most often care for cats and dogs, but also treat other pets, such as birds, ferrets, and rabbits. Companion animal veterinarians specialize in the care of small animals like cats, dogs, and some pocket pets. They are called General Practitioners and would be the equivalent of your family doctor. A small animal veterinarian is responsible for the diagnosis and treatment of sickness, disease and injury in companion animals like dogs, cats, rabbits, caged birds, and other small pets. A Doctor of Veterinary Medicine (DVM) is required to become a small animal veterinarian.

Get Free Sample Copy pages@ https://www.visionresearchreports.com/report/sample/39082

Report Coverage

Report Scope Details
Market Size US$ 40.8 billion by 2030
Growth Rate CAGR of 10.6% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Animal type
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Merck & Co., Inc.; Ceva; Vetoquinol S.A.; Zoetis; Boehringer Ingelheim International GmbH; Elanco; Virbac; Bimeda, Inc.; Norbrook; Calier

Growth Factors

Increasing prevalence of diseases in pets, rising pet expenditure, humanization of pets, adoption of online channels for buying pet medicines, and initiatives by key companies are the factors anticipated to fuel the market in the coming years. According to a 2021 article in the BMC Veterinary Research Journal, for instance, the prevalence of dental disorders diagnosed in dogs in the U.K. was found to be 14.10% and skin disorders were found to be 12.6%.

The rising number of pets across the globe, the trend of pet humanization has gained traction in several key markets. Pet parents are becoming increasingly aware of their pet’s health, treatment, and wellbeing. This has increased the adoption of pet insurance to reduce the financial risks for pet parents. Petplan- the largest pet insurance provider in the U.K. offers insurance policies for various species including dogs, cats, horses, small mammals, birds, reptiles, rabbits, and multi-pet owners.

By Regional Scope

North America held the largest revenue share of about 36.0%. This was owing to initiatives by the government and private sector, rising adoption of pet insurance, and the presence of key companies.

In Asia Pacific, the market is anticipated to witness the fastest CAGR of about 10.0% during the forecast period. The factors attributable to this growth include the growing pet population, the presence of local players, and an increasing number of vet clinics and hospitals.

What is our report scope?

This report focuses on the xxx market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. The xxx market report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.

COVID-19 has compressed the global economy and with it the manufacturing and marketing sector, production, disruption, financial.

The significant drop in COVID-19 cases due to mass inoculations programs worldwide are anticipated to increase revenue flow in the global economy and contribute to the growth of the car electrical products market. The COVID-19 impact has changed the growth projections of many sectors and businesses. The analysts put their excellent and well-researched opinions in the report. The opinions will help the stakeholders to make their strategy accordingly.

Key Players

  • Merck & Co., Inc.
  • Ceva
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Virbac
  • Bimeda, Inc.
  • Norbrook
  • Calier

Market Segmentation

  • Companion Animal Medicine Animal Type
    • Dogs
      • By Product
        • Biologics
          • Vaccines
            • By Type
              • Attenuated Live Vaccines
              • Inactivated Vaccines
              • Recombinant Vaccines
              • Toxoid
              • Others
            • By Indication
              • Distemper
              • Kennel cough (Parainfluenza)
              • Parvovirus
              • Canine herpes
              • Lyme Disease
              • Rabies
          • Others
        • Pharmaceuticals
          • Parasiticides
          • Anti-infectives
          • Anti-inflammatory
          • Analgesics
          • Others
        • Medicated Feed Additives
      • By Indication
        • Infectious Diseases
        • Dermatologic Diseases
        • Pain
        • Orthopedic Diseases
        • Behavioral Diseases
        • Other Indications
      • By Distribution Channel
        • Retail
        • E-Commerce
        • Hospital Pharmacy
    • Cats
      • By Product
        • Biologics
          • Vaccines
            • By Type
              • Attenuated Live Vaccines
              • Inactivated Vaccines
              • Recombinant Vaccines
              • Toxoid
              • Others
            • By Indication
              • Distemper
              • Kennel cough (Parainfluenza)
              • Parvovirus
              • Canine herpes
              • Lyme Disease
              • Rabies
          • Others
        • Pharmaceuticals
          • Parasiticides
          • Anti-infectives
          • Anti-inflammatory
          • Analgesics
          • Others
        • Medicated Feed Additives
      • By Indication
        • Infectious Diseases
        • Dermatologic Diseases
        • Pain
        • Orthopedic Diseases
        • Behavioral Diseases
        • Other Indications
      • By Distribution Channel
        • Retail
        • E-Commerce
        • Hospital Pharmacy
    •  Horses
      • By Product
        • Biologics
          • Vaccines
            • Attenuated Live Vaccines
            • Inactivated Vaccines
            • Recombinant Vaccines
            • Toxoid
            • Others
          • Others
        • Pharmaceuticals
          • Parasiticides
          • Anti-infectives
          • Anti-inflammatory
          • Analgesics
          • Others
        • Medicated Feed Additives
      • By Indication
        • Infectious Diseases
        • Dermatologic Diseases
        • Pain
        • Orthopedic Diseases
        • Behavioral Diseases
        • Other Indications
      • By Distribution Channel
        • Retail
        • E-Commerce
        • Hospital Pharmacy
  • Companion Animal Medicine Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • China
      • India
      • Japan
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia

Reasons to Purchase this Report:

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Companion Animal Medicine Market, By Animal Type

7.1.  Companion Animal Medicine Market, by Animal Type, 2021-2030

7.1.1.    Dogs

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Cats

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Horses

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Companion Animal Medicine Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Animal Type (2017-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Animal Type (2017-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Animal Type (2017-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Animal Type (2017-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Animal Type (2017-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Animal Type (2017-2030)

Chapter 9.    Company Profiles

9.1.  Merck & Co., Inc.

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Ceva

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Vetoquinol S.A.

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Zoetis

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Boehringer Ingelheim International GmbH

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Elanco

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Virbac

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  Bimeda, Inc.

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

Glossary of Terms

Buy This Report, click here@  https://www.visionresearchreports.com/report/cart/39082

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button